WT
UTHR icon

Wilmington Trust’s United Therapeutics UTHR Stock Holding History

Wilmington Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$299K Buy
3,387
+1,207
+55% +$116K 0.01% 617
2014
Q1 		$205K Buy
+2,180
New +$223K ﹤0.01% 681

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Wilmington Trust's UTHR Position: Q2 2014 in Review

Wilmington Trust increased its United Therapeutics (UTHR) stake by 55% in Q2 2014, buying an estimated $116K and bringing the position to 3,387 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #617.

Wilmington Trust first reported a position in UTHR in Q1 2014 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold UTHR as of Q2 2014.

  • Wilmington Trust held 3,387 shares of United Therapeutics worth $299K as of Q2 2014.
  • Wilmington Trust bought 1,207 United Therapeutics shares in Q2 2014, an estimated $116K.
  • United Therapeutics made up 0.01% of Wilmington Trust's portfolio in Q2 2014, its #617 holding.
  • Wilmington Trust first reported a position in United Therapeutics in Q1 2014 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.